ID   ENPP2_RAT               Reviewed;         887 AA.
AC   Q64610; Q66HQ0;
DT   19-SEP-2002, integrated into UniProtKB/Swiss-Prot.
DT   20-MAR-2007, sequence version 2.
DT   24-JUN-2015, entry version 123.
DE   RecName: Full=Ectonucleotide pyrophosphatase/phosphodiesterase family member 2;
DE            Short=E-NPP 2;
DE            EC=3.1.4.39;
DE   AltName: Full=Autotaxin;
DE   AltName: Full=Extracellular lysophospholipase D;
DE            Short=LysoPLD;
DE   Flags: Precursor;
GN   Name=Enpp2; Synonyms=Atx, Npps2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley; TISSUE=Brain;
RX   PubMed=7961762;
RA   Narita M., Goji J., Nakamura H., Sano K.;
RT   "Molecular cloning, expression, and localization of a brain-specific
RT   phosphodiesterase I/nucleotide pyrophosphatase (PD-Ialpha) from rat
RT   brain.";
RL   J. Biol. Chem. 269:28235-28242(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), PROTEIN SEQUENCE OF 28-32 AND
RP   36-41, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=16436050; DOI=10.1111/j.1365-2443.2006.00924.x;
RA   Koike S., Keino-Masu K., Ohto T., Masu M.;
RT   "The N-terminal hydrophobic sequence of autotaxin (ENPP2) functions as
RT   a signal peptide.";
RL   Genes Cells 11:133-142(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=12119361; DOI=10.1083/jcb.200204026;
RA   Umezu-Goto M., Kishi Y., Taira A., Hama K., Dohmae N., Takio K.,
RA   Yamori T., Mills G.B., Inoue K., Aoki J., Arai H.;
RT   "Autotaxin has lysophospholipase D activity leading to tumor cell
RT   growth and motility by lysophosphatidic acid production.";
RL   J. Cell Biol. 158:227-233(2002).
RN   [5]
RP   CHARACTERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-171;
RP   THR-209; ASP-311 AND HIS-315.
RX   PubMed=12633853; DOI=10.1016/S0014-5793(03)00133-9;
RA   Gijsbers R., Aoki J., Arai H., Bollen M.;
RT   "The hydrolysis of lysophospholipids and nucleotides by autotaxin
RT   (NPP2) involves a single catalytic site.";
RL   FEBS Lett. 538:60-64(2003).
RN   [6]
RP   PROTEOLYTIC PROCESSING, PROTEIN SEQUENCE OF N-TERMINUS, FUNCTION
RP   CHARACTERIZATION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ILE-13;
RP   16-PHE--PHE-18; 18-PHE--SER-21; 21-SER--ILE-24; 24-ILE--CYS-25 AND
RP   28-PHE--ALA-30.
RX   PubMed=15985467; DOI=10.1242/jcs.02438;
RA   Jansen S., Stefan C., Creemers J.W., Waelkens E., Van Eynde A.,
RA   Stalmans W., Bollen M.;
RT   "Proteolytic maturation and activation of autotaxin (NPP2), a secreted
RT   metastasis-enhancing lysophospholipase D.";
RL   J. Cell Sci. 118:3081-3089(2005).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 36-862 IN COMPLEX WITH
RP   INHIBITOR AND ZINC IONS, CATALYTIC ACTIVITY, COFACTOR, CALCIUM
RP   BINDING, DISULFIDE BONDS, GLYCOSYLATION AT ASN-524, ACTIVE SITE,
RP   MUTAGENESIS OF LYS-430 AND 764-ASP--ASP-768, AND SUBCELLULAR LOCATION.
RX   PubMed=21240271; DOI=10.1038/nsmb.1980;
RA   Hausmann J., Kamtekar S., Christodoulou E., Day J.E., Wu T.,
RA   Fulkerson Z., Albers H.M., van Meeteren L.A., Houben A.J.,
RA   van Zeijl L., Jansen S., Andries M., Hall T., Pegg L.E., Benson T.E.,
RA   Kasiem M., Harlos K., Kooi C.W., Smyth S.S., Ovaa H., Bollen M.,
RA   Morris A.J., Moolenaar W.H., Perrakis A.;
RT   "Structural basis of substrate discrimination and integrin binding by
RT   autotaxin.";
RL   Nat. Struct. Mol. Biol. 18:198-204(2011).
CC   -!- FUNCTION: Hydrolyzes lysophospholipids to produce lysophosphatidic
CC       acid (LPA) in extracellular fluids. Major substrate is
CC       lysophosphatidylcholine. Also can act on
CC       sphingosylphosphphorylcholine producing sphingosine-1-phosphate, a
CC       modulator of cell motility. Can hydrolyze, in vitro, bis-pNPP, to
CC       some extent pNP-TMP, and barely ATP. Involved in several motility-
CC       related processes such as angiogenesis and neurite outgrowth. Acts
CC       as an angiogenic factor by stimulating migration of smooth muscle
CC       cells and microtubule formation. Stimulates migration of melanoma
CC       cells, probably via a pertussis toxin-sensitive G protein. May
CC       have a role in induction of parturition. Possible involvement in
CC       cell proliferation and adipose tissue development. Tumor cell
CC       motility-stimulating factor. {ECO:0000269|PubMed:12119361,
CC       ECO:0000269|PubMed:15985467}.
CC   -!- CATALYTIC ACTIVITY: 1-alkyl-sn-glycero-3-phosphoethanolamine +
CC       H(2)O = 1-alkyl-sn-glycerol 3-phosphate + ethanolamine.
CC       {ECO:0000269|PubMed:21240271}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC         Evidence={ECO:0000269|PubMed:21240271};
CC       Note=Binds 2 Zn(2+) ions per subunit.
CC       {ECO:0000269|PubMed:21240271};
CC   -!- COFACTOR:
CC       Name=Ca(2+); Xref=ChEBI:CHEBI:29108;
CC         Evidence={ECO:0000269|PubMed:21240271};
CC       Note=Binds 1 Ca(2+) ion per subunit.
CC       {ECO:0000269|PubMed:21240271};
CC   -!- ENZYME REGULATION: Inhibited by lysophosphatidic acid (LPA) and
CC       sphingosine-1-phosphate (S1P). Inhibited by EDTA and EGTA (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:12119361,
CC       ECO:0000269|PubMed:12633853, ECO:0000269|PubMed:15985467,
CC       ECO:0000269|PubMed:16436050, ECO:0000269|PubMed:21240271}.
CC       Note=Secreted by most body fluids including serum and CSF. Also by
CC       adipocytes and numerous cancer cells.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q64610-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q64610-2; Sequence=VSP_024018;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in cerebrum and
CC       cerebellum. Localized in secretory epithelial cells in the brain
CC       and the eye including choroid plexus epithelial cells, ciliary
CC       epithelial cells, iris pigment epithelial cells, and retinal
CC       pigment cells. {ECO:0000269|PubMed:16436050,
CC       ECO:0000269|PubMed:7961762}.
CC   -!- PTM: N-glycosylation, but not furin-cleavage, plays a critical
CC       role on secretion and on lysoPLD activity. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the nucleotide
CC       pyrophosphatase/phosphodiesterase family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 SMB (somatomedin-B) domains. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D28560; BAA05910.1; -; mRNA.
DR   EMBL; DQ131564; AAZ99725.1; -; mRNA.
DR   EMBL; BC081747; AAH81747.1; -; mRNA.
DR   PIR; A55453; A55453.
DR   RefSeq; NP_476445.2; NM_057104.2.
DR   UniGene; Rn.20403; -.
DR   PDB; 2XR9; X-ray; 2.05 A; A=36-887.
DR   PDB; 2XRG; X-ray; 3.20 A; A=1-887.
DR   PDBsum; 2XR9; -.
DR   PDBsum; 2XRG; -.
DR   ProteinModelPortal; Q64610; -.
DR   MINT; MINT-4997409; -.
DR   PaxDb; Q64610; -.
DR   PRIDE; Q64610; -.
DR   GeneID; 84050; -.
DR   KEGG; rno:84050; -.
DR   UCSC; RGD:69298; rat. [Q64610-1]
DR   CTD; 5168; -.
DR   RGD; 69298; Enpp2.
DR   eggNOG; COG1524; -.
DR   HOGENOM; HOG000037439; -.
DR   HOVERGEN; HBG051484; -.
DR   InParanoid; Q64610; -.
DR   KO; K01122; -.
DR   PhylomeDB; Q64610; -.
DR   BRENDA; 3.1.4.39; 5301.
DR   SABIO-RK; Q64610; -.
DR   EvolutionaryTrace; Q64610; -.
DR   NextBio; 616633; -.
DR   PRO; PR:Q64610; -.
DR   Proteomes; UP000002494; Unplaced.
DR   Genevisible; Q64610; RN.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IDA:UniProtKB.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:RGD.
DR   GO; GO:0047391; F:alkylglycerophosphoethanolamine phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0005509; F:calcium ion binding; IDA:UniProtKB.
DR   GO; GO:0004622; F:lysophospholipase activity; IDA:UniProtKB.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0004551; F:nucleotide diphosphatase activity; IEA:InterPro.
DR   GO; GO:0004528; F:phosphodiesterase I activity; IMP:RGD.
DR   GO; GO:0030247; F:polysaccharide binding; IEA:InterPro.
DR   GO; GO:0005044; F:scavenger receptor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; IMP:RGD.
DR   GO; GO:0071276; P:cellular response to cadmium ion; IEP:RGD.
DR   GO; GO:0071392; P:cellular response to estradiol stimulus; IEP:RGD.
DR   GO; GO:0044849; P:estrous cycle; IEP:RGD.
DR   GO; GO:0006955; P:immune response; IEA:InterPro.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IDA:RGD.
DR   GO; GO:0090305; P:nucleic acid phosphodiester bond hydrolysis; IMP:GOC.
DR   GO; GO:0034638; P:phosphatidylcholine catabolic process; IDA:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IDA:RGD.
DR   GO; GO:0051894; P:positive regulation of focal adhesion assembly; IDA:RGD.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IDA:RGD.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; IDA:RGD.
DR   GO; GO:0045765; P:regulation of angiogenesis; IEA:InterPro.
DR   GO; GO:0030334; P:regulation of cell migration; IEA:InterPro.
DR   GO; GO:1903165; P:response to polycyclic arene; IEP:RGD.
DR   Gene3D; 3.40.570.10; -; 1.
DR   Gene3D; 3.40.720.10; -; 1.
DR   InterPro; IPR017849; Alkaline_Pase-like_a/b/a.
DR   InterPro; IPR017850; Alkaline_phosphatase_core.
DR   InterPro; IPR001604; DNA/RNA_non-sp_Endonuclease.
DR   InterPro; IPR024873; E-NPP.
DR   InterPro; IPR029881; ENPP2.
DR   InterPro; IPR020821; Extracellular_endonuc_su_A.
DR   InterPro; IPR002591; Phosphodiest/P_Trfase.
DR   InterPro; IPR020436; Somatomedin_B_chordata.
DR   InterPro; IPR001212; Somatomedin_B_dom.
DR   PANTHER; PTHR10151; PTHR10151; 1.
DR   PANTHER; PTHR10151:SF21; PTHR10151:SF21; 1.
DR   Pfam; PF01223; Endonuclease_NS; 1.
DR   Pfam; PF01663; Phosphodiest; 2.
DR   Pfam; PF01033; Somatomedin_B; 2.
DR   PRINTS; PR00022; SOMATOMEDINB.
DR   SMART; SM00892; Endonuclease_NS; 1.
DR   SMART; SM00477; NUC; 1.
DR   SMART; SM00201; SO; 2.
DR   SUPFAM; SSF53649; SSF53649; 1.
DR   PROSITE; PS00524; SMB_1; 2.
DR   PROSITE; PS50958; SMB_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Chemotaxis;
KW   Cleavage on pair of basic residues; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Glycoprotein; Hydrolase;
KW   Lipid degradation; Lipid metabolism; Metal-binding; Obesity;
KW   Reference proteome; Repeat; Secreted; Signal; Zinc.
FT   SIGNAL        1     27       {ECO:0000269|PubMed:15985467,
FT                                ECO:0000269|PubMed:16436050}.
FT   PROPEP       28     35       Removed by furin.
FT                                {ECO:0000269|PubMed:15985467,
FT                                ECO:0000269|PubMed:16436050}.
FT                                /FTId=PRO_0000281651.
FT   CHAIN        36    887       Ectonucleotide
FT                                pyrophosphatase/phosphodiesterase family
FT                                member 2.
FT                                /FTId=PRO_0000188569.
FT   DOMAIN       54     97       SMB 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00350}.
FT   DOMAIN       98    142       SMB 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00350}.
FT   REGION      210    213       Substrate binding. {ECO:0000250}.
FT   REGION      243    254       Substrate binding. {ECO:0000250}.
FT   REGION      854    875       Required for secretion. {ECO:0000250}.
FT   MOTIF       126    128       Cell attachment site. {ECO:0000255}.
FT   ACT_SITE    209    209       Nucleophile. {ECO:0000250}.
FT   METAL       171    171       Zinc 1; catalytic.
FT   METAL       209    209       Zinc 1; catalytic.
FT   METAL       311    311       Zinc 2; catalytic.
FT   METAL       315    315       Zinc 2; catalytic.
FT   METAL       315    315       Zinc 2; via tele nitrogen; catalytic.
FT                                {ECO:0000250}.
FT   METAL       358    358       Zinc 1; catalytic.
FT   METAL       359    359       Zinc 1; catalytic.
FT   METAL       359    359       Zinc 1; via tele nitrogen; catalytic.
FT                                {ECO:0000250}.
FT   METAL       474    474       Zinc 2; catalytic.
FT   METAL       474    474       Zinc 2; via tele nitrogen; catalytic.
FT                                {ECO:0000250}.
FT   METAL       764    764       Calcium.
FT   METAL       766    766       Calcium.
FT   METAL       768    768       Calcium.
FT   METAL       770    770       Calcium; via carbonyl oxygen.
FT   METAL       772    772       Calcium.
FT   BINDING     230    230       Substrate. {ECO:0000250}.
FT   BINDING     306    306       Substrate. {ECO:0000250}.
FT   SITE        877    877       Essential for catalytic activity.
FT                                {ECO:0000250}.
FT   CARBOHYD     53     53       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    398    398       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    410    410       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    524    524       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:21240271}.
FT   CARBOHYD    610    610       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    831    831       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID     58     75       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID     62     93       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID     73     86       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID     79     85       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    102    119       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    107    137       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    117    130       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    123    129       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    148    194       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    156    350       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    366    468       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    413    830       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    566    691       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    568    676       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   DISULFID    799    809       {ECO:0000255|PROSITE-ProRule:PRU00350,
FT                                ECO:0000269|PubMed:21240271}.
FT   VAR_SEQ     591    615       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:16436050}.
FT                                /FTId=VSP_024018.
FT   MUTAGEN      13     13       I->L: No effect on secretion.
FT                                {ECO:0000269|PubMed:15985467}.
FT   MUTAGEN      16     18       FTF->VLS: No effect on secretion.
FT                                {ECO:0000269|PubMed:15985467}.
FT   MUTAGEN      18     21       FAIS->SVCV: No effect on secretion.
FT                                {ECO:0000269|PubMed:15985467}.
FT   MUTAGEN      21     24       SVNI->VLTT: No effect on secretion.
FT                                {ECO:0000269|PubMed:15985467}.
FT   MUTAGEN      24     25       IC->TI: No effect on secretion.
FT                                {ECO:0000269|PubMed:15985467}.
FT   MUTAGEN      28     30       FTA->CIF: No effect on secretion.
FT                                {ECO:0000269|PubMed:15985467}.
FT   MUTAGEN     171    171       D->N: Abolishes lysophospholipase D
FT                                activity. {ECO:0000269|PubMed:12633853}.
FT   MUTAGEN     209    209       T->A: Abolishes lysophospholipase D
FT                                activity. {ECO:0000269|PubMed:12633853}.
FT   MUTAGEN     209    209       T->S: 15% of wild-type lysophospholipase
FT                                D activity.
FT                                {ECO:0000269|PubMed:12633853}.
FT   MUTAGEN     311    311       D->N: Abolishes lysophospholipase D
FT                                activity. {ECO:0000269|PubMed:12633853}.
FT   MUTAGEN     315    315       H->Q: 20% of wild-type lysophospholipase
FT                                D activity.
FT                                {ECO:0000269|PubMed:12633853}.
FT   MUTAGEN     430    430       K->A: Impaired secretion. No effect on
FT                                lysophospholipase activity.
FT                                {ECO:0000269|PubMed:21240271}.
FT   MUTAGEN     764    768       DYNYD->SYAYS: Abolishes secretion.
FT                                Strongly reduced lysophospholipase
FT                                activity. {ECO:0000269|PubMed:21240271}.
FT   CONFLICT     97     97       A -> V (in Ref. 1; BAA05910).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       C -> S (in Ref. 1; BAA05910).
FT                                {ECO:0000305}.
FT   CONFLICT    120    120       S -> P (in Ref. 1; BAA05910).
FT                                {ECO:0000305}.
FT   CONFLICT    147    162       DCEEIKVPECPAGFVR -> AARNQSSECLQVCP (in
FT                                Ref. 1; BAA05910). {ECO:0000305}.
FT   CONFLICT    198    198       A -> V (in Ref. 1; BAA05910).
FT                                {ECO:0000305}.
FT   CONFLICT    201    201       M -> T (in Ref. 1; BAA05910).
FT                                {ECO:0000305}.
FT   TURN         59     63       {ECO:0000244|PDB:2XR9}.
FT   STRAND       70     72       {ECO:0000244|PDB:2XR9}.
FT   TURN         77     83       {ECO:0000244|PDB:2XR9}.
FT   HELIX        89     92       {ECO:0000244|PDB:2XR9}.
FT   HELIX       104    106       {ECO:0000244|PDB:2XR9}.
FT   STRAND      115    118       {ECO:0000244|PDB:2XR9}.
FT   HELIX       123    126       {ECO:0000244|PDB:2XR9}.
FT   HELIX       133    138       {ECO:0000244|PDB:2XR9}.
FT   HELIX       143    145       {ECO:0000244|PDB:2XR9}.
FT   STRAND      165    171       {ECO:0000244|PDB:2XR9}.
FT   HELIX       175    180       {ECO:0000244|PDB:2XR9}.
FT   TURN        182    184       {ECO:0000244|PDB:2XR9}.
FT   HELIX       186    194       {ECO:0000244|PDB:2XR9}.
FT   STRAND      195    197       {ECO:0000244|PDB:2XR9}.
FT   HELIX       209    218       {ECO:0000244|PDB:2XR9}.
FT   HELIX       222    225       {ECO:0000244|PDB:2XR9}.
FT   STRAND      230    234       {ECO:0000244|PDB:2XR9}.
FT   TURN        235    238       {ECO:0000244|PDB:2XR9}.
FT   STRAND      239    241       {ECO:0000244|PDB:2XR9}.
FT   STRAND      243    246       {ECO:0000244|PDB:2XR9}.
FT   HELIX       247    249       {ECO:0000244|PDB:2XR9}.
FT   HELIX       251    253       {ECO:0000244|PDB:2XR9}.
FT   HELIX       259    265       {ECO:0000244|PDB:2XR9}.
FT   HELIX       281    292       {ECO:0000244|PDB:2XR9}.
FT   TURN        296    298       {ECO:0000244|PDB:2XR9}.
FT   STRAND      301    310       {ECO:0000244|PDB:2XR9}.
FT   HELIX       311    317       {ECO:0000244|PDB:2XR9}.
FT   HELIX       322    324       {ECO:0000244|PDB:2XR9}.
FT   HELIX       325    344       {ECO:0000244|PDB:2XR9}.
FT   TURN        348    350       {ECO:0000244|PDB:2XR9}.
FT   STRAND      352    358       {ECO:0000244|PDB:2XR9}.
FT   STRAND      368    371       {ECO:0000244|PDB:2XR9}.
FT   HELIX       372    374       {ECO:0000244|PDB:2XR9}.
FT   HELIX       379    381       {ECO:0000244|PDB:2XR9}.
FT   STRAND      382    385       {ECO:0000244|PDB:2XR9}.
FT   STRAND      387    395       {ECO:0000244|PDB:2XR9}.
FT   HELIX       404    410       {ECO:0000244|PDB:2XR9}.
FT   STRAND      420    424       {ECO:0000244|PDB:2XR9}.
FT   HELIX       425    427       {ECO:0000244|PDB:2XR9}.
FT   HELIX       430    432       {ECO:0000244|PDB:2XR9}.
FT   STRAND      442    447       {ECO:0000244|PDB:2XR9}.
FT   STRAND      452    455       {ECO:0000244|PDB:2XR9}.
FT   HELIX       481    483       {ECO:0000244|PDB:2XR9}.
FT   STRAND      487    491       {ECO:0000244|PDB:2XR9}.
FT   STRAND      496    499       {ECO:0000244|PDB:2XR9}.
FT   HELIX       505    507       {ECO:0000244|PDB:2XR9}.
FT   HELIX       508    515       {ECO:0000244|PDB:2XR9}.
FT   TURN        527    530       {ECO:0000244|PDB:2XR9}.
FT   HELIX       531    533       {ECO:0000244|PDB:2XR9}.
FT   STRAND      534    536       {ECO:0000244|PDB:2XR9}.
FT   HELIX       559    561       {ECO:0000244|PDB:2XR9}.
FT   HELIX       578    580       {ECO:0000244|PDB:2XR9}.
FT   TURN        583    586       {ECO:0000244|PDB:2XR9}.
FT   HELIX       617    620       {ECO:0000244|PDB:2XR9}.
FT   STRAND      634    638       {ECO:0000244|PDB:2XR9}.
FT   STRAND      643    647       {ECO:0000244|PDB:2XR9}.
FT   TURN        648    651       {ECO:0000244|PDB:2XR9}.
FT   STRAND      652    660       {ECO:0000244|PDB:2XR9}.
FT   HELIX       671    673       {ECO:0000244|PDB:2XR9}.
FT   HELIX       685    687       {ECO:0000244|PDB:2XR9}.
FT   HELIX       691    696       {ECO:0000244|PDB:2XR9}.
FT   STRAND      701    706       {ECO:0000244|PDB:2XR9}.
FT   HELIX       708    710       {ECO:0000244|PDB:2XR9}.
FT   HELIX       714    720       {ECO:0000244|PDB:2XR9}.
FT   HELIX       723    725       {ECO:0000244|PDB:2XR9}.
FT   STRAND      726    729       {ECO:0000244|PDB:2XR9}.
FT   HELIX       731    742       {ECO:0000244|PDB:2XR9}.
FT   HELIX       744    752       {ECO:0000244|PDB:2XR9}.
FT   STRAND      754    762       {ECO:0000244|PDB:2XR9}.
FT   STRAND      768    770       {ECO:0000244|PDB:2XR9}.
FT   HELIX       774    776       {ECO:0000244|PDB:2XR9}.
FT   STRAND      790    801       {ECO:0000244|PDB:2XR9}.
FT   HELIX       806    808       {ECO:0000244|PDB:2XR9}.
FT   STRAND      813    821       {ECO:0000244|PDB:2XR9}.
FT   TURN        830    833       {ECO:0000244|PDB:2XR9}.
FT   HELIX       836    838       {ECO:0000244|PDB:2XR9}.
FT   HELIX       840    846       {ECO:0000244|PDB:2XR9}.
FT   HELIX       851    858       {ECO:0000244|PDB:2XR9}.
FT   HELIX       870    878       {ECO:0000244|PDB:2XR9}.
SQ   SEQUENCE   887 AA;  101576 MW;  40AD1C957F833869 CRC64;
     MARQGCLGSF QVISLFTFAI SVNICLGFTA SRIKRAEWDE GPPTVLSDSP WTNTSGSCKG
     RCFELQEVGP PDCRCDNLCK SYSSCCHDFD ELCLKTARGW ECTKDRCGEV RNEENACHCS
     EDCLSRGDCC TNYQVVCKGE SHWVDDDCEE IKVPECPAGF VRPPLIIFSV DGFRASYMKK
     GSKVMPNIEK LRSCGTHAPY MRPVYPTKTF PNLYTLATGL YPESHGIVGN SMYDPVFDAS
     FHLRGREKFN HRWWGGQPLW ITATKQGVRA GTFFWSVSIP HERRILTILQ WLSLPDNERP
     SVYAFYSEQP DFSGHKYGPF GPEMTNPLRE IDKTVGQLMD GLKQLRLHRC VNVIFVGDHG
     MEDVTCDRTE FLSNYLTNVD DITLVPGTLG RIRAKSINNS KYDPKTIIAN LTCKKPDQHF
     KPYMKQHLPK RLHYANNRRI EDIHLLVDRR WHVARKPLDV YKKPSGKCFF QGDHGFDNKV
     NSMQTVFVGY GPTFKYRTKV PPFENIELYN VMCDLLGLKP APNNGTHGSL NHLLRTNTFR
     PTMPDEVSRP NYPGIMYLQS EFDLGCTCDD KVEPKNKLEE LNKRLHTKGS TEAETGKFRG
     SKHENKKNLN GSVEPRKERH LLYGRPAVLY RTSYDILYHT DFESGYSEIF LMPLWTSYTI
     SKQAEVSSIP EHLTNCVRPD VRVSPGFSQN CLAYKNDKQM SYGFLFPPYL SSSPEAKYDA
     FLVTNMVPMY PAFKRVWAYF QRVLVKKYAS ERNGVNVISG PIFDYNYDGL RDTEDEIKQY
     VEGSSIPVPT HYYSIITSCL DFTQPADKCD GPLSVSSFIL PHRPDNDESC NSSEDESKWV
     EELMKMHTAR VRDIEHLTGL DFYRKTSRSY SEILTLKTYL HTYESEI
//
